AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 14 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 5.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $10,707,000 | -18.8% | 16,600,000 | 0.0% | 0.38% | -17.7% |
| Q1 2018 | $13,186,000 | -0.1% | 16,600,000 | 0.0% | 0.46% | -11.9% |
| Q4 2017 | $13,195,000 | -1.2% | 16,600,000 | 0.0% | 0.52% | -13.8% |
| Q3 2017 | $13,359,000 | -0.8% | 16,600,000 | 0.0% | 0.60% | -16.2% |
| Q2 2017 | $13,462,000 | – | 16,600,000 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 9,000,000 | $6,728,000 | 2.88% |
| Context Capital Management, LLC | 1,250,000 | $941,000 | 1.71% |
| Tekla Capital Management LLC | 13,000,000 | $36,801,000 | 1.32% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,934,000 | $24,701,000 | 0.58% |
| ZAZOVE ASSOCIATES LLC | 16,360,000 | $12,321,000 | 0.57% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 42,500,000 | $31,769,000 | 0.49% |
| FALCON POINT CAPITAL, LLC | 1,500,000 | $1,121,000 | 0.40% |
| Amici Capital, LLC | 10,000,000 | $7,525,000 | 0.36% |
| Castle Creek Arbitrage, LLC | 4,000,000 | $3,037,000 | 0.24% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 15,000,000 | $11,556,000,000 | 0.24% |